Toxic epidermal necrolysis. (Q34004199)

30 July 2017

1 reference

title

Toxic epidermal necrolysis. (English)

1 reference

30 July 2017

Wolkenstein P

1

1 reference

30 July 2017

Revuz J

series ordinal

2

1 reference

30 July 2017

publication date

1 July 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

18

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

485-95, ix

1 reference

Toxic epidermal necrolysis: a review.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Toxic epidermal necrolysis (Lyell syndrome) in 77 elderly patients

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Carbamazepine ('Tegretol') and toxic epidermal necrolysis: report of three cases with histopathological observations

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Stevens-Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Observations on drug-induced toxic epidermal necrolysis in Singapore

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Intestinal involvement in drug-induced toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Evolving pattern of drug-induced toxic epidermal necrolysis.

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8 lymphocyte involvement

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Long-term complications of toxic epidermal necrolysis (Lyell's disease). Clinical and histopathologic study

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

HIV-1 infected patients with toxic epidermal necrolysis: an occupational risk for healthcare workers

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Toxic epidermal necrolysis associated with Mycoplasma pneumoniae infection

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Stevens-Johnson syndrome after mass prophylaxis with sulfadoxine for cholera in Mozambique

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Toxic epidermal necrolysis treated with cyclosporin

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Plasmapheresis in severe drug-induced toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Treatment of the cutaneous involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis with silver nitrate-impregnated dressings

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Toxic epidermal necrolysis: an eruption resembling scalding of the skin

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

A review of toxic epidermal necrolysis in Britain

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

The staphylococcal scalded-skin syndrome.

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Vulvovaginal Involvement in Toxic Epidermal Necrolysis: A Retrospective Study of 40 Cases

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Paraneoplastic pemphigus, pemphigus vulgaris, and pemphigus foliaceus

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Incidence of Toxic Epidermal Necrolysis in Italy

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Gelatinases in drug-induced toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Severe Cutaneous Drug Reactions (Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis) in Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Update on the Stevens-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Drug-induced toxic epidermal necrolysis treated with cyclosporin.

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Lymphocyte transformation test in drug-induced toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Genetic susceptibility to toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Sjögren-like syndrome after drug-induced toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Severe adverse cutaneous reactions to drugs

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Acute disseminated epidermal necrosis types 1, 2, and 3: study of sixty cases

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy"

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

A NEW ERUPTIVE FEVER ASSOCIATED WITH STOMATITIS AND OPHTHALMIA

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Corticosteroids for erythema multiforme?

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70196-0

7 January 2021

10.1016/S0733-8635(05)70196-0

Identifiers

DOI

1 reference

30 July 2017

1 reference